Correlation Between YS Biopharma and Amgen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both YS Biopharma and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YS Biopharma and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YS Biopharma Co and Amgen Inc, you can compare the effects of market volatilities on YS Biopharma and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YS Biopharma with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of YS Biopharma and Amgen.

Diversification Opportunities for YS Biopharma and Amgen

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between YS Biopharma and Amgen is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding YS Biopharma Co and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and YS Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YS Biopharma Co are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of YS Biopharma i.e., YS Biopharma and Amgen go up and down completely randomly.

Pair Corralation between YS Biopharma and Amgen

Allowing for the 90-day total investment horizon YS Biopharma Co is expected to generate 5.51 times more return on investment than Amgen. However, YS Biopharma is 5.51 times more volatile than Amgen Inc. It trades about 0.1 of its potential returns per unit of risk. Amgen Inc is currently generating about -0.19 per unit of risk. If you would invest  73.00  in YS Biopharma Co on January 29, 2024 and sell it today you would earn a total of  7.00  from holding YS Biopharma Co or generate 9.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

YS Biopharma Co  vs.  Amgen Inc

 Performance 
       Timeline  
YS Biopharma 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in YS Biopharma Co are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, YS Biopharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Amgen Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in May 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

YS Biopharma and Amgen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with YS Biopharma and Amgen

The main advantage of trading using opposite YS Biopharma and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YS Biopharma position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.
The idea behind YS Biopharma Co and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum